MEG3 and plasma cell myeloma: Previous research demonstrated that MEG3 promoted osteogenic differentiation of MSCs from patients with multiple myeloma, and our recent study displayed a similar promotion of osteogenesis on hASCs with MEG3 overexpression [22, 23].